May 26, 2023 (v1)
Publication
Background: Self-administered subcutaneous hepatitis B immunoglobulin (s.c. HBIg) in combination with nucleos(t)ide analogs (NUCs) has proved to be effective and safe in preventing hepatitis B virus (HBV) reinfection after liver transplantation. Material and methods: This non-interventional, prospective, single-arm, multicenter, international...
Uploaded on: May 27, 2023